Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs CoraDoc

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and CoraDoc head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 141 · Grade C

CoraDoc

Visit CoraDoc Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make CoraDoc a bad call — it's best for readers who prefer authorizing a new program themselves and can obtain the full payment and controlling refund policy before buying. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
72
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
80
Track Record
88
68
CoreAge RxBrief Score 94 · 71CoraDoc

Price, coverage & the tracker

CoreAge RxCoraDoc
Brief Score94/100 (A)71/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm full program payment

Advertised $77/mo equivalent requires a 12-month plan; confirm the full payment and supplied weeks. Clinical-decline refund terms conflict.

Full price details

Compounded semaglutide offered; complete program payment unknown; current $77/month equivalent requires a 12-month plan; earlier listing: From $99/mo (all doses, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm full program payment

Advertised $127/mo equivalent requires a 12-month plan; confirm the full payment and supplied weeks. Clinical-decline refund terms conflict.

Full price details

Compounded tirzepatide offered; complete program payment unknown; current $127/month equivalent requires a 12-month plan; earlier listing: From $165/mo (all doses, compounded)

CoverageUS only; restrictions by state, confirmed at intakeAdvertises all 50 states; confirm medication-specific clinical and pharmacy eligibility
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

CoraDoc: The $77/$127 equivalents require a 12-month plan and do not establish the full program charge. Refund policy retains $100 after a medically ineligible consultation, unlike full-refund marketing.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.